Aclarion, INC. (ACONW) — 10-Q Filings

All 10-Q filings from Aclarion, INC.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (6)

Aclarion's Losses Widen Amid Soaring Expenses, Despite Capital Influx — Nov 12, 2025 Risk: high
Aclarion, Inc. reported a net loss of $1,706,294 for the three months ended September 30, 2025, compared to a net loss of $1,366,176 for the same period in 2024
Aclarion's Cash Surges 2700% Amidst Widening Losses — Aug 14, 2025 Risk: high
Aclarion, Inc. (ACONW) reported a significant increase in cash and cash equivalents to $12,825,657 as of June 30, 2025, up from $453,661 on December 31, 2024, p
Aclarion, Inc. Files Q1 2025 10-Q — May 15, 2025 Risk: low
Aclarion, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly Nocimed, Inc., is incorporated in Delaware and operates in the medical
Aclarion, Inc. Files 10-Q for Q3 2024 — Nov 14, 2024 Risk: low
Aclarion, Inc. filed its 10-Q for the period ending September 30, 2024. The company, formerly known as Nocimed, Inc., is incorporated in Delaware and operates i
Aclarion, Inc. Files Q2 2024 10-Q Report — Aug 14, 2024 Risk: medium
Aclarion, Inc. filed its 10-Q for the period ending June 30, 2024. The company, formerly known as Nocimed, Inc., is based in Broomfield, CO. The filing covers t
Aclarion, Inc. Files 10-Q for Period Ending March 31, 2024 — May 15, 2024 Risk: low
Aclarion, Inc. (ACONW) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. Aclarion, Inc. filed its quarterly report (10-Q) for the period ending Marc

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX